Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Pharma 4.0

US$ 3,950.00

Report : This report provides detailed exposure to the Pharma 4.0 market. This report also highlights the current and future market potential of Pharma 4.0 along with a detailed analysis of the compet...

February 2021 72 pages

e-Pharmacy: Global Markets

US$ 5,500.00

Report : This report includes a detailed study of global and regional markets for various types of drugs, therapeutic categories and geographies. Estimated values are based on manufacturers’ total rev...

February 2021 86 pages

Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 183 pages

Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market Research Report by Technology (Barcodes, Forensic Markers, Holograms, Overt, Covert, & Forensic Features, and RfId), by End User (Apparel & Footwear, Automotive, Cosmetics & Personal Care, Electrical & Electronics, and Food & Beverage) - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 180 pages

Antibiotics Market Research Report by Drug Class (Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, and Macrolides), by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 193 pages

Antidiabetic Drug Market Research Report by Type (Alpha-glucosidase Inhibitors, Biguanides, DPP-IV (Dipeptidyl Peptidase) Inhibitors, GLP-1 (Glucagon-like Peptide) Agonists, and Insulin), by Disease (Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2), by Patient - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 194 pages

India COVID-19 Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)

US$ 1,190.00

India's COVID-19 vaccines market is anticipated to grow over US$ 2.3 Billion by 2027 with an impressive CAGR of more than 25% during the forecast period. The prominent factors that are expected to con...

February 2021 80 pages

IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026

US$ 3,750.00

... IV and oral iron drugs market by ROA can be segmented ino oral iron drugs and intravenous (IV) iron drugs. The oral iron drugs segment captured more than half of the market in 2018. Oral iron drugs are ...

February 2021 342 pages

Pharmaceutical Treatments for Mental Health Disorders: Global Markets

US$ 5,500.00

Report : This new report on the market for pharmaceutical treatments for mental health disorders provides a brief overview of the pharmaceutical markets, current and future treatments, as well as drug...

February 2021 128 pages

Analgesics Market Research Report by Type (Non-opioids and Opioids), by Route of Administration (Intravenous, Oral, Rectal, Topical, and Transdermal) - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 184 pages

Hormonal Contraceptives Market Research Report by Hormone Type (Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens), by Method Type (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, and Oral Contraceptives), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 198 pages

US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025

US$ 2,970.00

... on the following pointers: Market Penetration: Comprehensive information on product portfolios of the top players in the U.S. general anesthesia drugs market. The report analyzes the U.S. general anesthesia drugs market by molecule and mode of administration. Competitive Assessment: In-depth assessment of the market strategies, geographic and ...

February 2021 117 pages

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2021

US$ 1,500.00

... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Nausea and Vomiting The report also ...

February 2021 80 pages

Gallbladder cancer - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Gallbladder Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides ...

February 2021 60 pages

Yellow Fever- Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Yellow Fever - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Yellow Fever development. The report provides ...

February 2021 60 pages

Chronic inflammatory demyelinating polyneuropathy (CIDP) - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) The report also ...

February 2021 60 pages

End-Stage Renal Disease - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for End-Stage Kidney Disease The report also covers ...

February 2021 60 pages

Non-Small-Cell Lung Carcinoma (NSCLC) - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Small Cell Lung Cancer The report also ...

February 2021 60 pages

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) malignancy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Blastic plasmacytoid dendritic cell neoplasm (BPDCN) malignancy - Pipeline Insight, 2021,” report provides comprehensi...

February 2021 60 pages

Graves Ophthalmopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Graves Ophthalmopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...

February 2021 60 pages

IgA Nephropathy- Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “IgA Nephropathy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...

February 2021 60 pages

MALT Lymhoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights ab...

February 2021 60 pages

Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mild To Moderate Plaque Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...

February 2021 60 pages

Postoperative pain - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Postoperative pain - Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+...

February 2021 200 pages

ACALABRUTINIB - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “ACALABRUTINIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product...

February 2021 30 pages

Aliqopa - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Aliqopa - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...

February 2021 30 pages

ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...

February 2021 30 pages

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...

February 2021 30 pages

BI 764524 - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...

February 2021 30 pages

BLINATUMOMAB - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BLINATUMOMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...

February 2021 30 pages

BRENTUXIMAB VEDOTIN - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “BRENTUXIMAB VEDOTIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational pr...

February 2021 30 pages

DB-102 - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “DB-102 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Dif...

February 2021 30 pages

LONCASTUXIMAB TESIRINE - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “LONCASTUXIMAB TESIRINE - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational...

February 2021 30 pages

RG 7774 - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Di...

February 2021 30 pages

TREAKISYM - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “TREAKISYM - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...

February 2021 30 pages

UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigation...

February 2021 30 pages

VENGLUSTAT - Emerging Insight and Market Forecast - 2030

US$ 3,250.00

This report can be delivered to the clients within 48 Hours “VENGLUSTAT - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...

February 2021 30 pages

Zydelig - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Zydelig - Drug Insight and Market Forecast - 2030” report by DelveInsight outlays comprehensive insights of the product indicate...

February 2021 30 pages

Vitamin D Market - Global Outlook and Forecast 2021-2026

US$ 3,750.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vitamin D Market Report The vitamin D market by revenue is expected to grow at a CAGR of 8.4% during the pe...

February 2021 241 pages

Abnormal Glucose tolerance-Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Abnormal Glucose Tolerance – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...

February 2021 60 pages

Adult-onset growth hormone deficiency - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Adult-onset growth hormone deficiency - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ compa...

February 2021 60 pages

Advanced Hepatocellular Carcinoma with CPB liver cirrhosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Hepatocellular Carcinoma with CPB liver cirrhosis - Pipeline Insight, 2021,” report provides comprehensive in...

February 2021 60 pages

Advanced Non-squamous and squamous NSCLC - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Non-Squamous & Squamous NSCLC – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ com...

February 2021 60 pages

Advanced Urotheilal carcinoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Advanced Urothelial Carcinoma – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...

February 2021 60 pages

Alpha Thalassemia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Alpha Thalassemia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline...

February 2021 60 pages

C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021,” report provides comprehensive insights abo...

February 2021 60 pages

CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021,” report provides comprehensive insights...

February 2021 60 pages

CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ com...

February 2021 60 pages

CAR T-Cell Therapy for Non-Hodgkin’s lymphoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about...

February 2021 60 pages

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2021,” report provides comprehensive insights about...

February 2021 60 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1